Cigna Corporation (NYSE: CI) Stock Competitors & Peer Comparison
See CI's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CI and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CI | $300.26 | +1.58% | 80.1B | 9.81 | $30.90 | +2.06% |
| UNH | $401.86 | +1.07% | 363B | 21.73 | $18.64 | +2.25% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| CVS | $89.21 | +4.65% | 113.8B | 11.35 | $7.84 | +3.02% |
| ELV | $428.04 | +2.34% | 92.8B | 14.62 | $29.39 | +1.61% |
| HUM | $450.16 | +6.37% | 52.6B | 27.61 | $15.86 | +0.81% |
| CNC | $71.05 | +3.65% | 34.8B | 27.86 | $2.52 | N/A |
| MOH | $209.27 | +2.91% | 10.8B | 29.84 | $6.92 | N/A |
| OSCR | $32.69 | +1.71% | 8.7B | 23.92 | $1.40 | N/A |
| PGNY | $36.41 | +1.27% | 2.8B | 37.56 | $0.97 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
CI vs UNH Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, UNH has a market cap of 363B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while UNH trades at $401.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas UNH's P/E ratio is 21.73. In terms of profitability, CI's ROE is +0.14%, compared to UNH's ROE of +0.16%. Regarding short-term risk, CI is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for CI.Check UNH's competition here
Elevance Health Inc. (NYSE: ANTM)
CI vs ANTM Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas ANTM's P/E ratio is 18.99. In terms of profitability, CI's ROE is +0.14%, compared to ANTM's ROE of +0.12%. Regarding short-term risk, CI is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for CI.Check ANTM's competition here
CVS Health Corp. (NYSE: CVS)
CI vs CVS Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, CVS has a market cap of 113.8B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while CVS trades at $89.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas CVS's P/E ratio is 11.35. In terms of profitability, CI's ROE is +0.14%, compared to CVS's ROE of +0.14%. Regarding short-term risk, CI is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for CI.Check CVS's competition here
Elevance Health Inc. (NYSE: ELV)
CI vs ELV Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, ELV has a market cap of 92.8B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while ELV trades at $428.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas ELV's P/E ratio is 14.62. In terms of profitability, CI's ROE is +0.14%, compared to ELV's ROE of +0.12%. Regarding short-term risk, CI is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for CI.Check ELV's competition here
Humana Inc. (NYSE: HUM)
CI vs HUM Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, HUM has a market cap of 52.6B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while HUM trades at $450.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas HUM's P/E ratio is 27.61. In terms of profitability, CI's ROE is +0.14%, compared to HUM's ROE of +0.07%. Regarding short-term risk, CI is more volatile compared to HUM. This indicates higher risk in terms of short-term price fluctuations for CI.Check HUM's competition here
Centene Corp. (NYSE: CNC)
CI vs CNC Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, CNC has a market cap of 34.8B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while CNC trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas CNC's P/E ratio is 27.86. In terms of profitability, CI's ROE is +0.14%, compared to CNC's ROE of +0.07%. Regarding short-term risk, CI is more volatile compared to CNC. This indicates higher risk in terms of short-term price fluctuations for CI.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
CI vs MOH Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, MOH has a market cap of 10.8B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while MOH trades at $209.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas MOH's P/E ratio is 29.84. In terms of profitability, CI's ROE is +0.14%, compared to MOH's ROE of -0.01%. Regarding short-term risk, CI is more volatile compared to MOH. This indicates higher risk in terms of short-term price fluctuations for CI.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
CI vs OSCR Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, OSCR has a market cap of 8.7B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while OSCR trades at $32.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas OSCR's P/E ratio is 23.92. In terms of profitability, CI's ROE is +0.14%, compared to OSCR's ROE of +0.49%. Regarding short-term risk, CI is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for CI.Check OSCR's competition here
Progyny, Inc. (NASDAQ: PGNY)
CI vs PGNY Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, PGNY has a market cap of 2.8B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while PGNY trades at $36.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas PGNY's P/E ratio is 37.56. In terms of profitability, CI's ROE is +0.14%, compared to PGNY's ROE of +0.20%. Regarding short-term risk, CI is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for CI.Check PGNY's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
CI vs CLOV Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, CLOV has a market cap of 2.6B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while CLOV trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas CLOV's P/E ratio is 115.62. In terms of profitability, CI's ROE is +0.14%, compared to CLOV's ROE of +0.04%. Regarding short-term risk, CI is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for CI.Check CLOV's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
CI vs ALHC Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, ALHC has a market cap of 1.5B. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while ALHC trades at $7.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas ALHC's P/E ratio is 55.88. In terms of profitability, CI's ROE is +0.14%, compared to ALHC's ROE of +0.12%. Regarding short-term risk, CI is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for CI.Check ALHC's competition here
Bright Health Group, Inc. (NYSE: BHG)
CI vs BHG Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas BHG's P/E ratio is -0.12. In terms of profitability, CI's ROE is +0.14%, compared to BHG's ROE of +0.59%. Regarding short-term risk, CI is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for CI.Check BHG's competition here
Universal American Corporation (NYSE: UAM)
CI vs UAM Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, UAM has a market cap of 0. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas UAM's P/E ratio is 1.01. In terms of profitability, CI's ROE is +0.14%, compared to UAM's ROE of +0.17%. Regarding short-term risk, CI is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for CI.Check UAM's competition here
Aetna Inc. (NYSE: AET)
CI vs AET Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, AET has a market cap of 0. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas AET's P/E ratio is 9.57. In terms of profitability, CI's ROE is +0.14%, compared to AET's ROE of +0.11%. Regarding short-term risk, CI is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for CI.Check AET's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
CI vs MGLN Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas MGLN's P/E ratio is 8.49. In terms of profitability, CI's ROE is +0.14%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, CI is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for CI.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
CI vs GTS Comparison November 2026
Cigna Corporation (NYSE: CI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CI stands at 80.1B. In comparison, GTS has a market cap of 0. Regarding current trading prices, CI is priced at $300.26 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CI currently has a P/E ratio of 9.81, whereas GTS's P/E ratio is 10.41. In terms of profitability, CI's ROE is +0.14%, compared to GTS's ROE of +0.07%. Regarding short-term risk, CI is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for CI.Check GTS's competition here